摘要 |
The present invention relates to cancer therapies, compositions, and methods of using the same. In particular, the present invention provides methods of dosing and administration of cancer therapies comprising the administration of oligomers and liposome formulations of oligomers, wherein the cancer is mediated by the bcl-2 oncogene. In some aspects, the oligomers or liposome formulations of oligomers are administered in combination with one or more other therapeutic agents. |
申请人 |
PRONAI THERAPEUTICS, INC. |
发明人 |
RODRIGUEZA, WENDI, VELOSO;SOOCH, MINA, PATEL;GAYLOR, SHARI, KAY;MESSMANN, RICHARD, ADAM;WOOLLISCROFT, MICHAEL, JAMES |